Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project (PRODDIGE)
Primary Purpose
Cognitive Change
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
cognitive rehabilitation
Sponsored by
About this trial
This is an interventional prevention trial for Cognitive Change
Eligibility Criteria
Inclusion Criteria:
- Person with epilepsy, according to Fisher et al. (2005) criteria: all type of epilepsy could be include (new-onset and drug-resistant)
- Treatment must have been stable for 4 months: have the same molecule
- Person who has received full information about the organization of the research and has not objected to his or her participation and the use of his or her data
- Person aged 18 and over
- Mandatory affiliation to a social security scheme
- Validated cognitive inclusion criterion: having a YES response on the cognitive complaint questionnaire :
A.Spontaneous complaint :
Does the patient spontaneously complain of language difficulties?
B.Subjective complaint :
- Do you search for your words?
- Do you sometimes feel like you have the word on the tip of your tongue?
- Do you sometimes have trouble finding the names of people you know well?
- Do you ever say one word for another?
Exclusion Criteria:
- Person with another neurological condition
Patients and normal control :
- A person over the age of majority who is subject to a legal protection measure or who is unable to express their consent.
- Person deprived of liberty by a judicial or administrative decision
- A person who regularly uses psychoactive substances (cannabis, alcohol, etc.).
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Placebo Comparator
No Intervention
Arm Label
"application supervised by a psychologist via teleconsultations"
"application in total autonomy"
"control" group without using the application
Arm Description
patient have app, and teleconsultation with psychologist
patients have app, they play when they want
patients haven't app
Outcomes
Primary Outcome Measures
Number of weekly connections of epileptic patients in each group.
Evaluate the compliance to the digital application by counting the number of connections
Secondary Outcome Measures
Feeling the frequency of lexical access problems
Interview : Questionnaire language score : 0 to 12 points : 12 = worse outcome
Self-esteem assessment
Interview : Self-esteem score (Rosenberg scale) 0 to 40 points : 40 = better outcome
Mood assessment
Depression scale score (Neurological Disorder Depression Inventory for Epilepsy : NDDI-E) : 6 to 24 points : 24 = worse outcome
Anxiety assessment
Anxiety scale score : (Generalized Anxiety Disorder: GAD-7) : 0 to 21 points : 21 = worse outcome
Information processing speed
Computerized Speed Cognitive Test (CSCT): processing speed index: number of correct items in 90 sec. 0 to 110 points : 110 = better outcome
Lexicon access assessment
Lexicon access tests (Denomination Orale 80): number of correctly named words (0 to 80 words) : 80 = better outcome
lexicon access assessment in time
Lexicon access tests (Denomination Orale 80): time in second
Selective and sustained attention assessment
Selective Attention Test: Paced Auditory Serial Audition Test 4 seconds (PASAT): 0 to 60 score : 60 = better outcome
Working memory assessment
Backward digit span: number of digits recalled correctly in inverse order: 0 to 9 score: 9 = better outcome
Verbal fluency assessment
Verbal Initiation Test: Phonological Fluency: number of words beginning with P given in 2 minutes 0 to 50 words Category fluency test: number of words given in 2 minutes that belong to the category of Animals.0 to 50 words
Naming assessment Boston naming task
Number of correctly named words Boston Naming Test: number of correctly named words :0 to 50 points : 50 = better outcome
Naming assessment in time
Number of correctly named words Boston Naming Test: time in second
Naming assessment BETL
Number of correctly named words (BETL task : batterie evaluation troubles lexicaux = assessment of lexical impairment battery) 0 to 54 point : 54 = better outcome
Naming assessment BETL intime
BETL task : batterie evaluation troubles lexicaux = assessment of lexical impairment battery) : time in second
Full Information
NCT ID
NCT05057156
First Posted
June 29, 2021
Last Updated
September 15, 2021
Sponsor
Central Hospital, Nancy, France
Collaborators
UCB Pharma
1. Study Identification
Unique Protocol Identification Number
NCT05057156
Brief Title
Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project
Acronym
PRODDIGE
Official Title
Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 2021 (Anticipated)
Primary Completion Date
October 2023 (Anticipated)
Study Completion Date
March 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Central Hospital, Nancy, France
Collaborators
UCB Pharma
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Background: Epilepsy leads to cognitive impairment in 20-50%. Compared to seizures, these cognitive disorders are a major additional factor in occupational, social and family disability. Memory and language skills are most often impaired. These disorders are well described, multifactorial, but no therapy (drug and/or non-drug) has been validated to date. Recently, cognitive remediation techniques have shown benefits in certain neurological pathologies, such as multiple sclerosis. In adult epilepsy, few previous cognitive remediation studies were performed but suffer significant methodological shortcomings that limit the scope of their results. Studies that have focused on cognitive function have shown promising results for attention and memory. In contrast, in the area of language, no studies have been published.
Objective: to evaluate the effectiveness of a digital solution (PRODDIGE*) on the lexical access capacities in people with epilepsy.
Method: Randomized, multicentric, observational study which will compare the use of a digital solution (PRODDIGE) in total autonomy versus the supervised use by a trained neuropsychologist. A neuropsychological assessment will be provided before and after a period of 4 months of use of the digital solution.
Material: The medical project aims to offer an application of cognitive remediation to patients who suffer from cognitive impairments and especially language disorders.
T The App is like a serious game, it's based on the playfulness of "game" and the seriousness of "medical exercise". During the exercise the patient can ask for clues help and isn't constrained by time in order to succeed "his mission".
Conclusion: This will be the first French speaking app specifically dedicated to rehabilitation of language deficits observed in people with epilepsy. The expected benefits are an improvement of the patients' language complaints, the regular use of an adapted digital solution to improve their language difficulties, but also a better understanding of their disorders and an improvement of their self-esteem.
Detailed Description
o best help patients, Norsys enterprise designed the app with three key principles:
Co-designed, to encourage the emergence of original solutions about uses from patients and therapists,
User-friendly, to encourage the patient to exercise regularly and with pleasure (soft, optimistic, pleasant and calm mood),
Accessible design, to get an application compatible and adapted to the specifics of these patients (contrast, color, typography, manipulation) According to these principles, the app gives access to 6 mini-games in its first version and will be available on iOS and Android smartphones.
These exercises allow patients to work on specific aspects of their pathologies, this is how the exercises are intended to be playful, dynamic (ex. drag'n'drop) and sometimes collaborative.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cognitive Change
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
multicentric, transversal and randomized trial.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
90 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
"application supervised by a psychologist via teleconsultations"
Arm Type
Experimental
Arm Description
patient have app, and teleconsultation with psychologist
Arm Title
"application in total autonomy"
Arm Type
Placebo Comparator
Arm Description
patients have app, they play when they want
Arm Title
"control" group without using the application
Arm Type
No Intervention
Arm Description
patients haven't app
Intervention Type
Behavioral
Intervention Name(s)
cognitive rehabilitation
Intervention Description
patients have to use an app with cognitive games
Primary Outcome Measure Information:
Title
Number of weekly connections of epileptic patients in each group.
Description
Evaluate the compliance to the digital application by counting the number of connections
Time Frame
5 months
Secondary Outcome Measure Information:
Title
Feeling the frequency of lexical access problems
Description
Interview : Questionnaire language score : 0 to 12 points : 12 = worse outcome
Time Frame
0 and 5 months
Title
Self-esteem assessment
Description
Interview : Self-esteem score (Rosenberg scale) 0 to 40 points : 40 = better outcome
Time Frame
0 and 5 months
Title
Mood assessment
Description
Depression scale score (Neurological Disorder Depression Inventory for Epilepsy : NDDI-E) : 6 to 24 points : 24 = worse outcome
Time Frame
0 and 5 months
Title
Anxiety assessment
Description
Anxiety scale score : (Generalized Anxiety Disorder: GAD-7) : 0 to 21 points : 21 = worse outcome
Time Frame
0 and 5 months
Title
Information processing speed
Description
Computerized Speed Cognitive Test (CSCT): processing speed index: number of correct items in 90 sec. 0 to 110 points : 110 = better outcome
Time Frame
0 and 5 months
Title
Lexicon access assessment
Description
Lexicon access tests (Denomination Orale 80): number of correctly named words (0 to 80 words) : 80 = better outcome
Time Frame
0 and 5 months
Title
lexicon access assessment in time
Description
Lexicon access tests (Denomination Orale 80): time in second
Time Frame
0 and 5 months
Title
Selective and sustained attention assessment
Description
Selective Attention Test: Paced Auditory Serial Audition Test 4 seconds (PASAT): 0 to 60 score : 60 = better outcome
Time Frame
0 and 5 months
Title
Working memory assessment
Description
Backward digit span: number of digits recalled correctly in inverse order: 0 to 9 score: 9 = better outcome
Time Frame
0 and 5 months
Title
Verbal fluency assessment
Description
Verbal Initiation Test: Phonological Fluency: number of words beginning with P given in 2 minutes 0 to 50 words Category fluency test: number of words given in 2 minutes that belong to the category of Animals.0 to 50 words
Time Frame
0 and 5 months
Title
Naming assessment Boston naming task
Description
Number of correctly named words Boston Naming Test: number of correctly named words :0 to 50 points : 50 = better outcome
Time Frame
0 and 5 months
Title
Naming assessment in time
Description
Number of correctly named words Boston Naming Test: time in second
Time Frame
0 and 5 months
Title
Naming assessment BETL
Description
Number of correctly named words (BETL task : batterie evaluation troubles lexicaux = assessment of lexical impairment battery) 0 to 54 point : 54 = better outcome
Time Frame
0 and 5 months
Title
Naming assessment BETL intime
Description
BETL task : batterie evaluation troubles lexicaux = assessment of lexical impairment battery) : time in second
Time Frame
0 and 5 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Person with epilepsy, according to Fisher et al. (2005) criteria: all type of epilepsy could be include (new-onset and drug-resistant)
Treatment must have been stable for 4 months: have the same molecule
Person who has received full information about the organization of the research and has not objected to his or her participation and the use of his or her data
Person aged 18 and over
Mandatory affiliation to a social security scheme
Validated cognitive inclusion criterion: having a YES response on the cognitive complaint questionnaire :
A.Spontaneous complaint :
Does the patient spontaneously complain of language difficulties?
B.Subjective complaint :
Do you search for your words?
Do you sometimes feel like you have the word on the tip of your tongue?
Do you sometimes have trouble finding the names of people you know well?
Do you ever say one word for another?
Exclusion Criteria:
Person with another neurological condition
Patients and normal control :
A person over the age of majority who is subject to a legal protection measure or who is unable to express their consent.
Person deprived of liberty by a judicial or administrative decision
A person who regularly uses psychoactive substances (cannabis, alcohol, etc.).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
helene brissart, PhD, HDR
Phone
3383851689
Email
h.brissart@chru-nancy.fr
First Name & Middle Initial & Last Name or Official Title & Degree
louis maillard, Pr
Phone
383852377
Email
l.maillard@chru-nancy.fr
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project
We'll reach out to this number within 24 hrs